Search - tctmd.com

Displaying 1 - 20 of 183

Sort: Relevancy | Date

News Daily News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Yael L. Maxwell

December 05, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

Caitlin E. Cox

August 16, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

Advertisement

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Top Coronary Artery Disease News in 2024

Some Guidance for Managing Patients With AS and CAD: Review

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

DES Best for In-Stent Restenosis, but DCBs Also Viable

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

FDA Approves Bioresorbable Scaffold for BTK Lesions

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content